Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni
ACS Infectious Diseases · 08.08.2025 · 11 (8) · 2178-2189
DOI: 10.1021/acsinfecdis.5c00224 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 02.07.2025. Verfasst von Emanuele Fabbrizi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Schistosoma mansoni, Histone Demethylases, Tranylcypromine, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
- School of Pharmacy, Mekelle University, Mekelle 0231, Ethiopia.
- School of Pharmacy, University of East Anglia, Norwich NR4 7TJ, U.K.
- Institute of Molecular Biology and Pathology, National Research Council (CNR), Rome 00185, Italy.
- Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, Pavia 27100, Italy.
- Swiss Tropical and Public Health Institute, University of Basel, 4002 Allschwil, Switzerland, 4001 Basel, Switzerland.
ORCID-Profile: A Ganesan, Clemens Zwergel, Chiara Lambona, Sergio Valente, Andrea Mattevi, Dante Rotili, Antonello Mai
Förderung
- European Research Council
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dell'Universit? e della Ricerca
- EU COST Action
- Ateneo Sapienza Project
Zitieren
APA
Fabbrizi, E., Hailu, G. S., Ganesan, A., Fioravanti, R., Zwergel, C., Lambona, C., Valente, S., Fianco, G., Iuzzolino, A., Trisciuoglio, D., Caroli, J., Mattevi, A., Häberli, C., Keiser, J., Rotili, D., & Mai, A. (2025). Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni. ACS Infectious Diseases, 11(8), 2178-2189. https://doi.org/10.1021/acsinfecdis.5c00224
Vancouver
Fabbrizi E, Hailu GS, Ganesan A, Fioravanti R, Zwergel C, Lambona C, et al. Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni. ACS Infectious Diseases. 2025;11(8):2178-2189. doi:10.1021/acsinfecdis.5c00224
BibTeX
@article{Fabbrizi2025,
author = {Fabbrizi, Emanuele and Hailu, Gebremedhin Solomon and Ganesan, A and Fioravanti, Rossella and Zwergel, Clemens and Lambona, Chiara and Valente, Sergio and Fianco, Giulia and Iuzzolino, Angela and Trisciuoglio, Daniela and Caroli, Jonatan and Mattevi, Andrea and Häberli, Cécile and Keiser, Jennifer and Rotili, Dante and Mai, Antonello},
title = {Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni},
journal = {ACS Infectious Diseases},
year = {2025},
volume = {11},
number = {8},
pages = {2178--2189},
doi = {10.1021/acsinfecdis.5c00224}
}
EUVIMED